Journal of Neurochemistry, 1471-4159

Tidskrift

Fler filtreringsmöjligheter
  1. Debate/Note/Editorial
  2. mTOR: at the crossroads of aging, chaperones, and Alzheimer's disease.

    Gunnar Gouras, 2013, I : Journal of Neurochemistry. 124, 6, s. 747-748

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  3. Mind the gut: secretion of alpha-synuclein by enteric neurons

    Stefan A. Grathwohl, Jennifer A. Steiner, Markus Britschgi & Patrik Brundin, 2013, I : Journal of Neurochemistry. 125, 4, s. 487-490

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  4. Changes in the Tyrosine Phosphorylation of Mitogen‐Activated Protein Kinase in the Rat Hippocampus During and Following Severe Hypoglycemia

    Junichi Kurihara, Bing‐Ren ‐R Hu & Tadeusz Wieloch, 1994 jan 1, I : Journal of Neurochemistry. 63, 6, s. 2346-2348 3 s.

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  5. Publicerat konferensabstract
  6. Sphingosine-1-phosphate signaling in stroke-a potential role for astrocytes

    Hana Matuskova, Frank Matthes, Gabor Petzold & Anja Meissner, 2019 aug 3, I : Journal of Neurochemistry. 150, Suppl 1, s. 99-99

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  7. Targeting sphingosine-1-phosphate signaling to treat heart failure-induced memory deficits

    Anja Meissner, Franziska Uhl, Darcy Lidington, Frank Matthes, Lotte Vanherle & Steffen Sebastian Bolz, 2019 jul 1, I : Journal of Neurochemistry. 150, S1, s. 185-186 WTH04‐26.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  8. NEUROPEPTIDE AND HYPOTHALAMUS CHANGES IN FRONTOTEMPORAL DEMENTIA AND HUNTINGTON'S DISEASE

    G. Halliday, Åsa Petersén & O. Piguet, 2010, I : Journal of Neurochemistry. 115, Suppl. 1, s. 1-1

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  9. CELL THERAPY FOR PARKINSON'S DISEASE: PERSPECTIVES ON THE CLINICAL EXPERIENCE

    Deniz Kirik, 2010, I : Journal of Neurochemistry. 115, Suppl. 1, s. 2-2

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  10. Are the animal models of Parkinson's disease suitable for development of neuroprotective therapies?

    Deniz Kirik & Ayse Ulusoy, 2009, I : Journal of Neurochemistry. 110, Suppl 1, s. 63

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  11. Alzheimer's A beta 1-42 Peptide Interaction with alpha 1-antichymotrypsin in Vitro

    Y.X. Sun, Sabina Janciauskiene & J. Jia, 2009, I : Journal of Neurochemistry. 110, s. 64-64

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  12. Översiktsartikel
  13. How is alpha-synuclein cleared from the cell?

    Leonidas Stefanis, Evangelia Emmanouilidou, Marina Pantazopoulou, Deniz Kirik, Kostas Vekrellis & George K. Tofaris, 2019, I : Journal of Neurochemistry. 150, 5, s. 577-590

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  14. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?

    Laura A Volpicelli-Daley, Deniz Kirik, Lindsay E Stoyka, David G Standaert & Ashley S Harms, 2016 okt 1, I : Journal of Neurochemistry. 139, S1, s. 131-155 25 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  15. Diabetes in Friedreich Ataxia

    Miriam Cnop, Hindrik Mulder & Mariana Igoillo-Esteve, 2013, I : Journal of Neurochemistry. 126, s. 94-102

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

Föregående 1 2 3 4 5 Nästa